Skip to content

Use of statins to control multiple sclerosis to go into large trials

By Catholic Online (NEWS CONSORTIUM)
3/19/2014 (3 years ago)
Catholic Online (www.catholic.org)

Cholesterol-lowering pills slow brain shrinkage in MS patients

The University College London has announced that large trials in the use of statins to control multiple sclerosis, or MS can now begin. According to the medical journal the Lancet, early trial results show the cholesterol-lowering pills slow brain shrinkage in people with MS.

Researchers believe statins may have anti-inflammatory and neuroprotective properties that can guard the nerves from damage.

Researchers believe statins may have anti-inflammatory and neuroprotective properties that can guard the nerves from damage.

Highlights

By Catholic Online (NEWS CONSORTIUM)
Catholic Online (www.catholic.org)
3/19/2014 (3 years ago)

Published in Health

Keywords: Statins, multiple scelrosis, medical trials


LOS ANGELES, CA (Catholic Online) - The trials will confirm whether statins benefit MS patients by slowing progression of the disease and easing their symptoms.

Half of all MS patients after 10 years go on to develop more advanced disease - known as secondary progressive MS. It is this later stage disease that Dr. Jeremy Chataway and colleagues at UCL hope to treat with low cost statins.

Prayer, fasting and almsgiving.

No licensed drugs to date have shown a convincing impact on this later stage of the disease.

As published in the Lancet, Dr. Chataway's team, for their phase two trial randomly assigned 140 people with secondary progressive MS to receive either 80 milligrams of a statin called simvastatin -- or a placebo for two years.

The high, daily dose of simvastatin was well tolerated and slowed brain shrinkage by 43 percent over two years compared with the placebo.

"Caution should be taken regarding over-interpretation of our brain imaging findings, because these might not necessarily translate into clinical benefit. However, our promising results warrant further investigation in larger phase three disability-driven trials," Dr. Chataway says.

Researchers believe statins may have anti-inflammatory and neuroprotective properties that can guard the nerves from damage.

Jacqueline Palace from the John Radcliffe Hospital, Oxford and Neil Robertson from Cardiff University in Wales, in an accompanying editorial, said the trial represented a promising starting point in the quest to find a treatment for secondary progressive MS.

"There are no treatments that can stop the condition from worsening in people with progressive MS," Dr. Susan Kohlhaas, head of biomedical research at the MS Society, says. "Scientists have worked for years to find a potential treatment that could help people, and now, finally, one has been found that might. This is very exciting news.

"Further, larger clinical trials are now absolutely crucial to confirm the safety and effectiveness of this treatment."

MS remains a major cause of disability. The condition affects nerves in the brain and spinal cord, which causes problems with muscle movement, balance and vision. There is currently no cure, although there are treatments that can help in the early stages of the disease.

---


'Help give every student and teacher Free resources for a world-class moral Catholic education'


Copyright 2017 - Distributed by THE CALIFORNIA NETWORK

Pope Francis Prayer Intentions for APRIL 2017
Young People.
That young people may respond generously to their vocations and seriously consider offering themselves to God in the priesthood or consecrated life.


Comments


More Health

Has the Fountain of Youth FINALLY been discovered? Watch

Image of Can umbilical cord plasma reverse the brain's aging?

A new Stanford study revealed what many believe could be the first step to a true cure for aging. LOS ANGELES, CA (Catholic Online) - The ... continue reading


Can cancer REALLY be cured by a simple vitamin? Watch

Image of Can vitamins really cure cancer?

Scientists believe an extremely high dose of one vitamin may be the cure for cancer. LOS ANGELES, CA (Catholic Online) - There have been ... continue reading


Two-thirds of cancers may have a surprising cause that we can do nothing about Watch

Image of Scientists have found that two-thirds of all cancer cases may be the result of random, bad-luck mutations.

If you are afraid of cancer, we have bad news. There may be little way to avoid the dreaded disease. A new study affirms that two-thirds of ... continue reading


Neil Gorsuch and end-of-life care: What ethical stance does he take? Watch

Image of Neil Gorsuch offers his views on end-of-life care.

Supreme Court nominee Neil Gorsuch made a crucial ethical distinction in his response to questions about doctor-prescribed suicide during ... continue reading


'Three-parent babies' are coming. We are resistant to wisdom, let's pray we are resistant to the consequences Watch

Image of Designer babies have arrived.

British doctors have been given the OK to create embryos from three parents to prevent genetic diseases. The first such child could be born ... continue reading


Never Miss any Updates!

Stay up to date with the latest news, information, and special offers.

Catholic Online Logo

Copyright 2017 Catholic Online. All materials contained on this site, whether written, audible or visual are the exclusive property of Catholic Online and are protected under U.S. and International copyright laws, © Copyright 2017 Catholic Online. Any unauthorized use, without prior written consent of Catholic Online is strictly forbidden and prohibited.